Baidu
map

中医养生馆不能针灸!国家中医药管理局发文了

2018-06-08 于小渔 基层医师公社

与中医诊所相比,中医类的养生机构能够开展的技术范围一直比较模糊,到底哪些能做,哪些不能做?这次官方回应了!近日,国家中医药管理局发布了《国家中医药管理局办公室关于非医疗机构开展“火疗”项目的复函》(国中医药办医政函[2018]79号)(以下简称《复函》),对于中医养生保健机构可以开展以及禁止开展的技术方法进行了说明。《复函》中明确表示,中医养生保健机构可以使用中医技术,但禁止使用具有创伤性、侵入性

与中医诊所相比,中医类的养生机构能够开展的技术范围一直比较模糊,到底哪些能做,哪些不能做?这次官方回应了!

近日,国家中医药管理局发布了《国家中医药管理局办公室关于非医疗机构开展“火疗”项目的复函》(国中医药办医政函[2018]79号)(以下简称《复函》),对于中医养生保健机构可以开展以及禁止开展的技术方法进行了说明。

《复函》中明确表示,中医养生保健机构可以使用中医技术,但禁止使用具有创伤性、侵入性或者危险性的技术方法,如针刺、瘢痕灸、发泡灸、牵引、扳法、中医微创类技术、中医灌洗肠等技术。

中医养生保健机构是非医疗机构,但中医技术却是其谋生手段,因此一直以来对于中医养生保健机构可以开展的技术范围都比较模糊,不少中医养生馆的经营者都不太清楚自己有没有“越界”。

其实,早在2014年,国家中医药管理局办公室和国家卫计委办公厅就发布了《关于打击非法行医专项行动中有关中医监督问题的批复》(国中医药办法监发〔2014〕9号),对一些地方就打击非法行医工作中有关中医监督问题提出请示,做了批复。主要有以下几点:

1.中医诊疗活动的概念

中医诊疗活动是以疾病诊断和治疗为目的,在中医理论指导下通过各种检查,使用药物、技术、器械及手术等方法,对疾病作出判断和消除疾病、缓解病情、减轻痛苦、改善功能、延长生命、帮助患者恢复健康的活动。

2.非医疗机构不得使用针刺等技术

非医疗机构及其人员在经营活动中不得使用针刺、瘢痕灸、发泡灸、牵引、扳法、中医微创类技术、中药灌洗肠以及其他具有创伤性、侵入性或者高危险性的技术方法;不得开具药品处方;不得宣传治疗作用;不得给服务对象口服不符合《既是食品又是药品的物品名单》、《可用于保健食品的物品名单》规定的中药饮片或者《保健食品禁用物品名单》规定禁用的中药饮片。

对违反规定的行为,应当按照《执业医师法》、《医疗机构管理条例》等有关法律法规进行处理。涉嫌犯罪的,依法移送司法机关。

3.开展气功活动需符合规定

任何机构和人员开展医疗气功活动,应当符合原卫生部《医疗气功管理暂行规定》(卫生部令第12号)的规定。

4.这些宣传术语使用有风险

在中医医疗监督工作中,发现以涉及中医药的“预防”、“保健”、“养生”、“气功治病”、“医学研究”、“疾病研究”、“健康咨询”、“理疗”等为名,或假借中医理论和术语开展宣传、培训、讲座、体验等涉嫌虚假宣传、欺诈消费者,牟取不正当利益的行为,对不属于本机关管辖的,应当按照《行政处罚法》、《卫生行政处罚程序》的有关规定移送有管辖权的机关处理。

纵观以上规定,不难看出,市面上的中医养生保健机构,不少家都有涉及到针刺、牵引、发泡灸等违规操作,大家总觉得只要不出事就没啥风险。

但随着国家对中医、护理方面监察力度的加大,这些行为早晚会得到管制,并且一旦出现事故,那可就“摊上大事”了,所以有这些行为的中医养生机构,还是尽快自查自纠,减少风险。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2019-05-15 123592b0m72暂无昵称

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2019-03-31 12565d26m93暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2018-06-10 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2018-06-08 天地飞扬

    学习一下.谢谢分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2018-06-08 执着追梦

    学习.谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2018-06-08 1e17414fm02(暂无匿称)

    学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=366250, encodeId=fbe33662500f, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Wed May 15 08:53:48 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363835, encodeId=482036383519, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78542562104, createdName=12565d26m93暂无昵称, createdTime=Sun Mar 31 00:14:53 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771272, encodeId=e6711e712723d, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Wed Oct 03 00:47:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409564, encodeId=6a4914095642f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 10 02:47:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322533, encodeId=87bf322533dc, content=学习一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Jun 08 14:37:16 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322511, encodeId=87a532251184, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Fri Jun 08 13:27:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322498, encodeId=705a322498c1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Fri Jun 08 12:02:08 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322494, encodeId=8d2f3224946c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 08 11:53:52 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2018-06-08 wzb521zf

    一起学习学习

    0

相关资讯

“中医针灸全球风采行”走进24个国家和地区

在世界针灸学会联合会成立30周年之际,由世界针灸学会联合会、中国中医科学院、世界卫生组织联合主办,中国针灸学会 、中国中医科学院针灸研究所承办的世界针灸学术大会暨2017中国针灸学会学术年会于近日在北京开幕。

中国针灸成世界上广泛的替代医学疗法

世界卫生组织统计数据显示,目前有103个会员国认可使用针灸,其中29个设立了传统医学的法律法规,18个将针灸纳入医疗保险体系。总部设在中国的世界针灸学会联合会有53个国家和地区的194个会员团体;世界中医药学会联合会亦拥有67个国家和地区的257个国际团体会员,146个专业委员会和13个产业发展(合作)委员会。

西班牙女子接受活蜂针灸后死亡 疗法安全性遭质疑

据加拿大电视网 (CTV)3 月 20 日报道,西班牙一名 55 岁的妇女在接受了一个疗程的活蜂针灸治疗后,出现了严重的过敏性反应,最终死于并发症。活蜂针灸一直被推崇为“天然的”愈伤方法,是缓解疼痛的良方。但是研究人员在调查了这名西班牙妇女的死因之后,认为这种疗法是“不安全且不可取的”。

针灸疗法对缓解癌症患者因芳香化酶抑制剂治疗引起的关节炎样疼痛有效

12月7日,美国史上最大规模探讨“针灸是否可缓解癌症患者疼痛”的临床试验在“乳腺癌研讨会(圣安东尼奥市,德克萨斯州)”上公布结果:226名分别来自美国11所不同癌症中心的乳腺癌患者临床数据显示,针灸疗法能显著减少正在进行激素治疗的乳腺癌患者痛感,能间接挽救患者生命,提高乳腺癌生存率。 由于阿片类止痛药物不仅有副作用,而且极易上瘾,美国许多癌症中心都开始提供其他止痛辅助疗法。近90%美国国立癌

ASCO 2018:癌症幸存者的失眠,针灸PK认知行为治疗

摘要编号:10001时间:6月3日8:00 AM~11:00AM专场:病人和幸存者护理 形式:口头报告  高达60%的癌症幸存者有常见的失眠问题,神奇的针灸治疗与酷炫的认知行为治疗,对这一群体究竟疗效如何?本项研究将这两种疗法一一比拼,一分高下! 本项研究纳入了160例伴有失眠的治疗后癌症幸存者,进行了针灸与认知行为治疗的随机临床试验。针灸涉及用针刺激身体穴

JAMA:针灸不能提高人工授精女性新生儿活产率

研究认为,在卵泡刺激和胚胎移植前后接受针灸不能增加人工授精女性的新生儿活产率

Baidu
map
Baidu
map
Baidu
map